Averto Medical raised $30.5M in a series A financing led by Cormorant Asset Management to advance ColoSeal™ Intraluminal Diversion System for clinical testing and regulatory approvals.
May 07, 2024•over 1 year ago
Amount Raised
$30.5 Million
Round Type
series a
FremontMedicalBiotechnologyHealth CareInvestors
CvfLife Sci Venture PartnersVenrock Healthcare Capital PartnersCormorant Asset Management
Description
Averto Medical closed an oversubscribed $30.5 million series A financing led by Cormorant Asset Management with participation from Venrock Healthcare Capital Partners, LifeSci Venture Partners, CVF, and other investors. The funding will support advancing Averto Medical's clinical testing of the ColoSeal™ Intraluminal Diversion System towards regulatory approvals, targeting a multi-billion dollar market opportunity.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech